Karol K.
- Country
- Poland
- Department
- Zakład Medycyny Populacyjnej i Prewencji Chorób Cywilizacyjnych
Research Overview
- Phase 2 Study of REGN13335 Efficacy and Safety in Adults with Pulmonary Arterial Hypertension
- A Randomized, Placebo‑Controlled Trial of Zenagamtide (NNC0487‑0111) in Obese Patients with HFpEF or HFmrEF to Reduce CV Death and HF Hospitalization
- Evaluation of Empagliflozin on Exercise Capacity in Patients with Hypertrophic Cardiomyopathy: A Randomized, Placebo-Controlled Trial
Data & Insights
Has run more than one trial at 115 of 432 partner sites.
Specializations
Pulmonary Arterial Hypertension Expertise
The investigator specializes in pulmonary arterial hypertension (PAH) research, conducting extensive studies on novel therapeutic approaches and long-term treatment outcomes. Their work encompasses evaluation of various therapeutic agents for managing PAH symptoms and improving patient prognosis.
- Novel therapeutic interventions
- Long-term safety assessments
- Treatment optimization strategies
Their research extends to investigating combination therapies and background treatment modifications in PAH management.
Complex Cardiac Conditions
The investigator focuses on complex cardiac conditions including hypertrophic cardiomyopathy and heart failure with preserved ejection fraction (HFpEF). Their research explores innovative treatment approaches for these challenging cardiovascular conditions.
- Exercise capacity improvement
- Cardiac function enhancement
- Treatment efficacy evaluation
Their work includes assessment of therapeutic interventions for cardiac conditions with associated pulmonary complications.
Advanced Pulmonary Disorders
The investigator studies complex pulmonary conditions including chronic thromboembolic pulmonary hypertension and combined postcapillary and precapillary pulmonary hypertension. Their research focuses on understanding disease mechanisms and developing targeted treatments.
- Pulmonary vascular resistance
- Hemodynamic improvements
- Clinical outcome measures
Their expertise includes evaluation of therapeutic interventions for various forms of pulmonary hypertension.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.